Meiji Holdings Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 10 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/08/04 | ¥52.38 | ¥56.33 | +7.6% |
| 2026/05/14 | ¥3.34 | ¥-13.82 | -513.2% |
| 2026/02/12 | ¥71.33 | ¥63.97 | -10.3% |
| 2025/11/12 | ¥47.97 | ¥42.00 | -12.4% |
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
3.6M | -0.44% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
2.4M | +2.51% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.8M | +0.37% | |
|
Dimensional ETF Trust-Dimensional International Value ETF
|
1.2M | +18.19% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
891.5K | -8.98% | |
|
DFA INVESTMENT TRUST CO-The DFA International Value Series
|
679.2K | +2.82% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
2.4K | -4.59% |
Dividend History 4Years Growth
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥108 | +4.9% |
| 2025 | ¥103 | +5.1% |
| 2024 | ¥98 | +2.6% |
| 2023 | ¥95 | +8.6% |
| 2022 | ¥88 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥1,013,092M | ¥1,062,157M | ¥1,105,494M | ¥1,154,074M |
| Gross Profit | ¥323,249M | ¥306,802M | ¥327,345M | ¥339,100M |
| Operating Income | ¥92,922M | ¥75,434M | ¥84,322M | ¥84,702M |
| Pretax Income | ¥128,955M | ¥95,872M | ¥87,874M | ¥82,864M |
| Net Income | ¥87,497M | ¥69,424M | ¥50,675M | ¥50,800M |
| EPS | ¥303.62 | ¥247.39 | ¥181.56 | ¥186.08 |
| Operating Margin | 9.17% | 7.10% | 7.63% | 7.34% |
| Balance Sheet | ||||
| Total Assets | ¥1,117,459M | ¥1,136,217M | ¥1,205,288M | ¥1,184,472M |
| Total Equity | ¥673,335M | ¥711,915M | ¥746,529M | ¥748,288M |
| Total Liabilities | ¥444,124M | ¥424,302M | ¥458,759M | ¥436,184M |
| Cash | ¥67,409M | ¥63,519M | ¥106,858M | ¥78,191M |
| Interest-bearing Debt | ¥81,266M | ¥64,370M | ¥49,926M | ¥47,799M |
| Equity Ratio | 60.26% | 62.66% | 61.94% | 63.17% |
| D/E Ratio | 0.12 | 0.09 | 0.07 | 0.06 |
| Cash Flow | ||||
| Operating CF | ¥127,526M | ¥85,013M | ¥107,983M | ¥68,979M |
| Investing CF | -¥27,614M | -¥36,788M | -¥24,604M | -¥40,636M |
| Financing CF | -¥76,997M | -¥54,734M | -¥43,772M | -¥61,671M |
| Free CF | ¥34,361M | ¥12,843M | ¥54,539M | ¥12,356M |
| Efficiency | ||||
| ROE | 12.99% | 9.75% | 6.79% | 6.79% |
| ROA | 7.83% | 6.11% | 4.20% | 4.29% |
Latest IR Information
-
Notice Regarding Change in Consolidated Subsidiary (Share Transfer)
Resolved to transfer the shares of consolidated subsidiary Nihon Kanzume Co., Ltd. to Yoshimura Food Holdings. The transfer is scheduled for 2026/11/01. Nihon Kanzume is a 100% subsidiary of Meiji and a third-party allotment of shares is planned to eliminate...
Read more -
Conclusion of Joint Venture and Share Transfer Agreements for Succession of Kyorin Pharmaceutical's Generic Drug Business by Meiji Holdings Co., Ltd. and Three Other Companies
Establish a pharmaceutical co-creation entity through joint investment to succeed Kyorin Pharmaceutical's generic drug business. The co-creation entity will be capitalized by Daito, Meiji Seika Pharma and DBJ, and is planned to be established in December 2026. Preliminary transactions will...
Read more -
Notice regarding completion of payment for the disposition of treasury stock under an incentive plan using restricted stock for employees and partial lapse of rights
Regarding the disposition of treasury stock under an employee incentive plan using restricted stock, payment has been completed and partial lapse of rights has occurred. The number of shares disposed after changes is 16,300 shares, and the total disposed amount...
Read more -
Q1 FY2027 Financial Summary (Consolidated)
For Q1 of the fiscal year ending March 2027, consolidated net sales were 289,401 million yen (up 5.8% YoY), operating income was 22,673 million yen (up 27.7% YoY), ordinary income was 24,790 million yen (up 37.8% YoY), and net income...
Read more -
Notice Regarding the Share Transfer of Meiji's China Business | July 2026
Meiji Holdings will transfer its milk and yogurt business in China to Shanghai Aojia Food, and is progressing with portfolio restructuring. The transfer amount is approximately 7.6 billion yen, scheduled for December 2026. The company plans to focus management resources...
Read more
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥4,655
Rating Score: 2.10 (Based on 10 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Meiji Holdings Co., Ltd., together with its subsidiaries, manufactures and sells food products and pharmaceuticals in Japan, China, Asia, North America, Europe, and internationally. It operates in two segments, Food and Pharmaceuticals. The company offers milk, yogurt, cheese, ice cream, chocolate, gummy candy, protein, nutrition for infants and children, beauty supplements, and nutritional products. It also provides drugs for infectious diseases and central nervous system disorders, as well as vaccines, blood plasma products, generic drugs, and animal health products. The company was founded in 1916 and is headquartered in Chuo, Japan.
